IP Library Assignment 030292/0960
Patent Assignment
Reel/Frame 030292/0960

Corrective Assignment to Correct the City Name in the Address of the Assignee from Forster City to Foster City Previously Recorded on Reel 028008 Frame 0234. Assignor(S) Hereby Confirms the Assignee.

Recorded: 2013-04-24 Pages: 5
Assignors
MITCHELL, SCOTT A.
Executed: 2012-04-04
CURRIE, KEVIN S.
Executed: 2012-04-04
Assignee
GILEAD CONNECTICUT, INC.
333 LAKESIDE DRIVE, FOSTER CITY, CALIFORNIA, 94404
Covered Property (1)
6-(1H-Indazol-6-Yl)-N-[4-(Morpholin-4-Yl)Phenyl]Imidazo-[1,2-A]Pyrazin-8-Amine, or a Pharmaceutically Acceptable Salt Thereof, as a Syk Inhibitor
Patent: 8,450,321 →
Application: 13/441,441 →
Publication: US 2012/0220582
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 6, 2012
From: MITCHELL, SCOTT A.; CURRIE, KEVIN S.
To: GILEAD CONNECTICUT, INC.
Reel/Frame 028008/0234 →
Merger and Change of Name Sep 17, 2020
From: COUGAR MERGER SUB, INC.; CGI PHARMACEUTICALS, INC.; CGI PHARMACEUTICALS, INC.
To: GILEAD CONNECTICUT, INC.
Reel/Frame 053799/0190 →
Assignment of Assignor's Interest Sep 30, 2020
From: GILEAD CONNECTICUT, INC.
To: KRONOS BIO, INC.
Reel/Frame 053927/0969 →